PSMA-PET/CT imaging for prostate cancer: Current knowledge and its future role in the Canadian landscape
PSMA-PET/CT imaging for prostate cancer: Current knowledge and its future role in the Canadian landscape
Webinar Recording from April 20, 2023
Speakers: Frédéric Pouliot, Glenn Bauman, Sebastien Hotte, Katherine Zukotynski
At the conclusion of this program, participants should be able to:
- Recognize available imaging modalities
- Review a comparative analyses of imaging modalities and existing evidence (conventional vs PSMA-PET)
- Discuss the impact of new generation of imaging on treatment approaches of advanced PCa
ACCREDITATION
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.
This program has received financial support from AstraZeneca/Merck in the form of an educational grant.